These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8726546)

  • 1. Significantly higher plasma haloperidol level during cotreatment with carbamazepine may herald cardiac change.
    Iwahashi K
    Clin Neuropharmacol; 1996 Jun; 19(3):267-70. PubMed ID: 8726546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients.
    Hesslinger B; Normann C; Langosch JM; Klose P; Berger M; Walden J
    J Clin Psychopharmacol; 1999 Aug; 19(4):310-5. PubMed ID: 10440457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol.
    Leo R; Razzini C; Di Lorenzo G; Bianchi F; Tesauro M; Zanasi M; Siracusano A; Romeo F
    J Clin Psychiatry; 2008 Feb; 69(2):327-8. PubMed ID: 18363460
    [No Abstract]   [Full Text] [Related]  

  • 4. The drug-drug interaction effects of haloperidol on plasma carbamazepine levels.
    Iwahashi K; Miyatake R; Suwaki H; Hosokawa K; Ichikawa Y
    Clin Neuropharmacol; 1995 Jun; 18(3):233-6. PubMed ID: 8635181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of intravenous administration of the antipsychotic drug benperidol on the QT interval.
    Schmidt A; Fischer P; Wally B; Scharfetter J
    Neuropsychiatr; 2017 Dec; 31(4):172-175. PubMed ID: 28791627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac effects of haloperidol and carbamazepine treatment.
    Iwahashi K; Nakamura K; Miyatake R; Suwaki H; Hosokawa K
    Am J Psychiatry; 1996 Jan; 153(1):135. PubMed ID: 8540577
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.
    Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano RJ; O'Gorman C; Harrigan RH
    Clin Ther; 2010 Mar; 32(3):472-91. PubMed ID: 20399985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis.
    Czekalla J; Beasley CM; Dellva MA; Berg PH; Grundy S
    J Clin Psychiatry; 2001 Mar; 62(3):191-8. PubMed ID: 11305706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QTc interval lengthening and debrisoquine metabolic ratio in psychiatric patients treated with oral haloperidol monotherapy.
    LLerena A; Berecz R; de la Rubia A; Dorado P
    Eur J Clin Pharmacol; 2002 Jun; 58(3):223-24. PubMed ID: 12162273
    [No Abstract]   [Full Text] [Related]  

  • 10. Intramuscular haloperidol or lorazepam and QT intervals in schizophrenia.
    Harvey AT; Flockhart D; Gorski JC; Greenblatt DJ; Burke M; Werder S; Preskorn SH
    J Clin Pharmacol; 2004 Oct; 44(10):1173-84. PubMed ID: 15342619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval.
    Barbui C; Bighelli I; Carrà G; Castellazzi M; Lucii C; Martinotti G; Nosè M; Ostuzzi G;
    PLoS One; 2016; 11(2):e0148212. PubMed ID: 26840602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual rate-dependent cardiac electrophysiologic effects of haloperidol: slowing of intraventricular conduction and lengthening of repolarization.
    Mörtl D; Agneter E; Krivanek P; Koppatz K; Todt H
    J Cardiovasc Pharmacol; 2003 Jun; 41(6):870-9. PubMed ID: 12775964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to Iwashashi: "significantly higher plasma haloperidol level during cotreatment with carbamazepine may herald cardiac change".
    Zuiderwijk PB; Lavrijsen K
    Clin Neuropharmacol; 1997 Apr; 20(2):179. PubMed ID: 9099473
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder.
    Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano R; O'Gorman C; Harrigan RH
    Pharmacotherapy; 2010 Feb; 30(2):127-35. PubMed ID: 20099987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in QTc prolongation induced by zotepine following a switch to perospirone.
    Suzuki Y; Watanabe J; Sugai T; Fukui N; Ono S; Tsuneyama N; Saito M; Someya T
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):244. PubMed ID: 22443250
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium.
    Vandael E; Vandenberk B; Vandenberghe J; Spriet I; Willems R; Foulon V
    Int J Clin Pharm; 2016 Apr; 38(2):310-20. PubMed ID: 26749342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic drugs and QT interval prolongation.
    Zareba W; Lin DA
    Psychiatr Q; 2003; 74(3):291-306. PubMed ID: 12918603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature.
    Lawrence KR; Nasraway SA
    Pharmacotherapy; 1997; 17(3):531-7. PubMed ID: 9165555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QTc prolongation: possible association with risperidone and/or haloperidol.
    Nandagopal JJ; Craig JM; Lippmann S
    Psychosomatics; 2003; 44(6):521. PubMed ID: 14597690
    [No Abstract]   [Full Text] [Related]  

  • 20. QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia.
    Ozeki Y; Fujii K; Kurimoto N; Yamada N; Okawa M; Aoki T; Takahashi J; Ishida N; Horie M; Kunugi H
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):401-5. PubMed ID: 20079791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.